Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Remarks:
Type of genotoxicity: gene mutation
Type of information:
migrated information: read-across from supporting substance (structural analogue or surrogate)
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: see 'Remark'
Remarks:
GLP - Guideline study, tested with the source substance bis(2-ethylhexyl)nonanedioate (CAS 103-24-2). In accordance to the ECHA guidance document “Practical guide 6: How to report read-across and categories (March 2010)”, the reliability was changed from RL1 to RL2 to reflect the fact that this study was conducted on a read-across substance.

Data source

Referenceopen allclose all

Reference Type:
study report
Title:
Unnamed
Year:
2004
Report date:
2004
Reference Type:
publication
Title:
Reverse Mutation Test of Bis(2-ethylhexyl) azelate in Bacteria
Author:
Miwa, Y.
Year:
2004
Bibliographic source:
Toxicity Testing Reports of Environmental Chemicals, 11, 287-320
Reference Type:
secondary source
Title:
Bis(2-ethylhexyl) azelate
Author:
OECD
Year:
2006
Bibliographic source:
SIDS Initial Assessment Report for SIAM 22, Paris, France, 18-21 April, 2006
Reference Type:
secondary source
Title:
Diesters Category of the Aliphatic Esters Chemicals (Test Plan and Robust Summaries for Substances in the HPV Test Plan)
Author:
US-EPA (American Chemistry Council's Aliphatic Esters Panel)
Year:
2010
Bibliographic source:
High Production Volume (HPV) Chemical Challenge Program (201-16837A and 201-16837B)

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
Deviations:
no
GLP compliance:
yes
Type of assay:
bacterial reverse mutation assay

Test material

Constituent 1
Reference substance name:
103-24-2 (analytical purity 77.2%)
IUPAC Name:
103-24-2 (analytical purity 77.2%)
Details on test material:
- Name of test material (as cited in study report): Bis(2-ethylhexyl)nonanedioate
- Analytical purity: 77.2%
- Impurities (identity and concentrations):
Bis(2-ethylhexyl)glutarate 2.2%,
Bis(2-ethylhexyl)adipate 2.4%,
Bis(2-ethylhexyl)pimelate 2.8%,
Bis(2-ethylhexyl)suberate 3.8%,
Bis(2-ethylhexyl)sebacate 3.3%,
Bis(2-ethylhexyl) 1-,9-nonamethylenedicarboxylate 5.3%,
Bis(2-ethylhexyl)1-,10-decamethylenedicarboxylate 0.6%,
Bis(2-ethylhexyl)1-,11-undecamethylenedicarboxylate 0.3%
- Lot/batch No.: N-31101

Method

Target gene:
His operon (S. typhimurium)
Trp operon (E. coli)
Species / strainopen allclose all
Species / strain / cell type:
S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
Species / strain / cell type:
E. coli WP2 uvr A
Metabolic activation:
with and without
Metabolic activation system:
cofactor supplemented post-mitochondrial fraction (S9 mix), prepared from the livers of rats treated with phenobarbital and 5,6-benzoflavone.
Test concentrations with justification for top dose:
Range finding test:
1.22, 4.88, 19.5, 78.1, 312.5, 625, 1250 and 5000 µg/plate with and without metabolic activation
Main test:
312.5, 625, 1250, 2500 and 5000 µg/plate with and without metabolic activation
Vehicle / solvent:
- Vehicle(s)/solvent(s) used: ethanol
Controls
Untreated negative controls:
yes
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Positive control substance:
other: -S9: 2-(2-Furyl)-3-(5-nitro-2-furyl)acrylamide (AF2; 0.01 µg/plate: TA100, WP2uvrA; 0.1 µg/plate: TA98); sodium azide (SA; 0.5 µg/plate: TA1535); 9-aminoacridine (9AA; 80 µg/plate: TA1537); +S9: 2-aminoanthracene (2AA; up to 10 µg/plate all strains)
Details on test system and experimental conditions:
METHOD OF APPLICATION: in agar (plate incorporation)

DURATION
- Exposure duration: 48 h

NUMBER OF REPLICATIONS: triplicates each in two independent experiments

DETERMINATION OF CYTOTOXICITY
- Method: relative total growth
Evaluation criteria:
If the number of colonies with revertants was as double as that of control group and dose response was observed, the interpretation of the result was positive.
Statistics:
Mean values and standard deviation were calculated.

Results and discussion

Test resultsopen allclose all
Species / strain:
S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Species / strain:
E. coli WP2 uvr A
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Additional information on results:
TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: There were colorless clear fine oil drop-like precipitations and oil membrane-like precipitations on the surface of agar in any test concentration.

RANGE-FINDING: No cytotoxicity was observed in a range finding study with doses up to 5000 µg/plate.
Remarks on result:
other: all strains/cell types tested
Remarks:
Migrated from field 'Test system'.

Any other information on results incl. tables

 Table 1. Test results of experiment 1 (plate incorporation)

With or without S9-Mix

Test substance concentration

Mean number of revertant colonies per plate

(μg/plate)

(average of 3 plates ± Standard deviation)

 

Base-pair substitution type

cross-linking type

Frameshift type

 

TA 100

TA1535

WP2 uvrA

TA98

TA1537

0 (aqua dest.)

102 ± 8.1

9 ± 2.6

35 ± 2.6

20 ± 3.5

5 ± 0.6

0 (vehicle)

110 ± 14

13 ± 6.2

27 ± 2.1

29 ± 4.2

7 ± 2.3

312.5

100 ± 9.3P

8 ± 2.1P

25 ± 7.0P

23 ± 0.6P

13 ± 3.1P

625

106 ± 2.6P

11 ± 2.6P

31 ± 6.5P

23 ± 4.2P

11 ± 0.6P

1250

112 ± 12.1P

10 ± 1.2P

26 ± 5.5P

29 ± 2.1P

6 ± 0.6P

2500

94 ± 2.5P

9 ± 2.5P

29 ± 2.6P

27 ± 4.0P

10 ± 3.5P

5000

92 ± 11.5P

7 ± 1.0P

24 ± 1.5P

23 ± 5.0P

4 ± 0.6P

Positive controls,
-S9 mix

Name

AF2

SA

AF2

AF2

9AA

Concentrations (μg/plate)

0.01

0.5

0.01

0.1

80

Mean No. of colonies/plate (average of 3 ± SD)

548 ± 7.8

525 ± 7.1

132 ± 6.5

421 ± 11.2

334 ± 87.7

+

0 (medium)

106 ± 12.1

11 ± 0.6

24 ± 3.5

30 ± 3.0

13 ± 1.0

+

0 (vehicle)

105 ± 12

10 ± 4.0

33 ± 7.2

27 ± 3.5

16 ± 3.8

+

312.5

103 ± 8.1P

7 ± 4.4P

30 ± 6.1P

25 ± 4.6P

13 ± 1.7P

+

625

96 ± 8.1P

7 ± 2.6P

31 ± 4.6P

31 ± 8.0P

11 ± 1.5P

+

1250

97 ± 15.6P

9 ± 2.6P

31 ± 5.0P

31 ± 6.4P

14 ± 1.5P

+

2500

96 ± 9.7P

6 ± 3.2P

33 ± 2.6P

25 ± 7.5P

11 ± 2.0P

+

5000

90 ± 3.2P

7 ± 4.2P

32 ± 5.8P

32 ± 5.5P

12 ± 2.9P

Positive controls,
+S9 mix

Name

2AA

2AA

2AA

2AA

2AA

Concentrations (μg/plate)

1

2

10

0.5

2

Mean No. of colonies/plate (average of 3 ± SD)

1036 ± 46.9

327± 18.4

969 ± 142.3

437 ± 30.3

181 ± 29.5

AF2 = 2-(2-Furyl)-3-(5-nitro-2-furyl)acrylamide

9AA = 9-aminoacridine

2AA = 2-aminoanthracene

SA = sodium azide

P = Precipitate

Table 2. Test results of experiment 2 (plate incorporation)

With or without S9-Mix

Test substance concentration

Mean number of revertant colonies per plate

(μg/plate)

(average of 3 plates ± Standard deviation)

 

Base-pair substitution type

cross-linking type

Frameshift type

TA 100

TA1535

WP2 uvrA

TA98

TA1537

0 (aqua dest.)

132 ± 15.5

8 ± 1.0

39 ± 2.5

23 ± 8.1

9 ± 5.5

0 (vehicle)

131 ± 14.5

9 ± 3.1

41 ± 6.1

31 ± 6.9

9 ± 3.0

312.5

129 ± 17.1P

7 ± 2.1P

38 ± 7.0P

27 ± 4.2P

10 ± 1.5P

625

124 ± 5.2P

7 ± 1.2P

33 ± 7.8P

30 ± 11P

14 ± 5.2P

1250

127 ± 10.4P

8 ± 1.5P

34 ± 4.0P

30 ± 2.1P

13 ± 1.0P

2500

128 ± 16.8P

8 ± 3.8P

38 ± 3.2P

25 ± 1.0P

13 ± 3.6P

5000

124 ± 4.0P

10 ± 2.5P

38 ± 0.0P

27 ± 4.0P

10 ± 2.5P

Positive controls,
- S9

Name

AF2

SA

AF2

AF2

9AA

Concentrations (μg/plate)

0.01

0.5

0.01

0.1

80

Mean No. of colonies/plate (average of 3 ± SD)

569 ± 27.5

589 ± 36.5

137 ± 17.6

446 ± 19.1

411 ± 100.1

+

0 (medium)

137 ± 16.1

7 ± 2.5

33 ± 3.2

31 ± 7.8

12 ± 3.0

+

0 (vehicle)

132 ± 5.2

7 ± 3.2

46 ± 7.2

31 ± 6.1

16 ± 2.1

+

312.5

125 ± 22.4P

7 ± 1.5P

39 ± 2.6P

23 ± 1.2P

12 ± 1.5P

+

625

123 ± 10.0P

8 ± 2.1P

41 ± 5.1P

31 ± 2.5P

14 ± 6.5P

+

1250

125 ± 14.0P

9 ± 3.2P

40 ± 5.7P

23 ± 4.5P

14 ± 4.2P

+

2500

116 ± 3.5P

8 ± 2.1P

39 ± 12.5P

31 ± 1.2P

17 ± 5.1P

+

5000

121 ± 7.6P

11 ± 3.8P

46 ± 4.0P

35 ± 2.5P

13 ± 2.1P

Positive controls,
+ S9

Name

2AA

2AA

2AA

2AA

2AA

Concentrations (μg/plate)

1

2

10

0.5

2

Mean No. of colonies/plate (average of 3 ± SD)

999 ± 117.8

289 ± 6.1

995 ± 77.9

420 ± 33.7

135 ± 13.1

AF2 = 2-(2-Furyl)-3-(5-nitro-2-furyl)acrylamide

9AA = 9-aminoacridine

2AA = 2-aminoanthracene

SA = sodium azide

P = Precipitate

Applicant's summary and conclusion

Conclusions:
Interpretation of results (migrated information):
negative